Although these latter studies did not focus on prostate cancer, they implicate a potential role of MYC exon 3 hypomethylation in the development or progression of cancer, which is consistent with the directions of our findings with regard to prostate tumor–normal tissue differences and differences by GS in prostate tumor tissue. The gene discussed is MYC; the disease is prostate neoplasm.